NovoBind Livestock Therapeutics Inc.
$967,480.00 CAD
≈ 13 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- January 9, 2023 – March 31, 2025
- Reference
- nrc-cnrc:172-2022-2023-Q4-1003474
Published purpose
This project will support the firm in furthering their development of nanobody-based prophylaxis agents targeting two economically-important pathogens of farmed shrimp. Nanobodies targeting one of the pathogens (Vibrio parahaemolyticus) will be validated in an industrial setting with field trials using a commercially-relevant shrimp species and proof of concept of the nanobodies' efficacy against the other pathogen (White Spot Syndrome Virus) will be demonstrated at the bench scale in a surrogate in vivo model.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions